These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23236279)

  • 1. Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses.
    Tsibane T; Ekiert DC; Krause JC; Martinez O; Crowe JE; Wilson IA; Basler CF
    PLoS Pathog; 2012; 8(12):e1003067. PubMed ID: 23236279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody.
    Wyrzucki A; Dreyfus C; Kohler I; Steck M; Wilson IA; Hangartner L
    J Virol; 2014 Jun; 88(12):7083-92. PubMed ID: 24719426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope mapping of the hemagglutinin molecule of A/(H1N1)pdm09 influenza virus by using monoclonal antibody escape mutants.
    Matsuzaki Y; Sugawara K; Nakauchi M; Takahashi Y; Onodera T; Tsunetsugu-Yokota Y; Matsumura T; Ato M; Kobayashi K; Shimotai Y; Mizuta K; Hongo S; Tashiro M; Nobusawa E
    J Virol; 2014 Nov; 88(21):12364-73. PubMed ID: 25122788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice.
    O'Donnell CD; Vogel L; Wright A; Das SR; Wrammert J; Li GM; McCausland M; Zheng NY; Yewdell JW; Ahmed R; Wilson PC; Subbarao K
    mBio; 2012; 3(3):. PubMed ID: 22647789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of conservative and variable epitopes of the pandemic influenza virus A(H1N1)pdm09 hemagglutinin using monoclonal antibodies].
    Masalova OV; Chichev EV; Fediakina IT; Mukasheva EA; Klimova RR; Shchelkanov MIu; Burtseva EI; Ivanova VT; Kushch AA; L'vov DK
    Vopr Virusol; 2014; 59(3):34-40. PubMed ID: 25335417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head.
    Benjamin E; Wang W; McAuliffe JM; Palmer-Hill FJ; Kallewaard NL; Chen Z; Suzich JA; Blair WS; Jin H; Zhu Q
    J Virol; 2014 Jun; 88(12):6743-50. PubMed ID: 24696468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site.
    Hong M; Lee PS; Hoffman RM; Zhu X; Krause JC; Laursen NS; Yoon SI; Song L; Tussey L; Crowe JE; Ward AB; Wilson IA
    J Virol; 2013 Nov; 87(22):12471-80. PubMed ID: 24027321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
    Yoshida R; Igarashi M; Ozaki H; Kishida N; Tomabechi D; Kida H; Ito K; Takada A
    PLoS Pathog; 2009 Mar; 5(3):e1000350. PubMed ID: 19300497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.
    Kaverin NV; Rudneva IA; Govorkova EA; Timofeeva TA; Shilov AA; Kochergin-Nikitsky KS; Krylov PS; Webster RG
    J Virol; 2007 Dec; 81(23):12911-7. PubMed ID: 17881439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin.
    Schmeisser F; Friedman R; Besho J; Lugovtsev V; Soto J; Wang W; Weiss C; Williams O; Xie H; Ye Z; Weir JP
    Influenza Other Respir Viruses; 2013 May; 7(3):480-90. PubMed ID: 23122228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations
    Davis AKF; McCormick K; Gumina ME; Petrie JG; Martin ET; Xue KS; Bloom JD; Monto AS; Bushman FD; Hensley SE
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.
    Rockman S; Camuglia S; Vandenberg K; Ong C; Baker MA; Nation RL; Li J; Velkov T
    Mol Immunol; 2013 Apr; 53(4):435-42. PubMed ID: 23127859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies specific for discontinuous epitopes direct refolding of influenza A virus hemagglutinin.
    Yewdell JW
    Mol Immunol; 2010 Feb; 47(5):1132-6. PubMed ID: 20047763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope mapping of the 2009 pandemic and the A/Brisbane/59/2007 seasonal (H1N1) influenza virus haemagglutinins using mAbs and escape mutants.
    Retamal M; Abed Y; Corbeil J; Boivin G
    J Gen Virol; 2014 Nov; 95(Pt 11):2377-2389. PubMed ID: 25078301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.
    Throsby M; van den Brink E; Jongeneelen M; Poon LL; Alard P; Cornelissen L; Bakker A; Cox F; van Deventer E; Guan Y; Cinatl J; ter Meulen J; Lasters I; Carsetti R; Peiris M; de Kruif J; Goudsmit J
    PLoS One; 2008; 3(12):e3942. PubMed ID: 19079604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of an enhanced antigenic change in the pandemic 2009 H1N1 influenza virus haemagglutinin.
    García-Barreno B; Delgado T; Benito S; Casas I; Pozo F; Cuevas MT; Mas V; Trento A; Rodriguez-Frandsen A; Falcón A; Ortín J; Nieto A; Melero JA
    J Gen Virol; 2014 May; 95(Pt 5):1033-1042. PubMed ID: 24531414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse antigenic site targeting of influenza hemagglutinin in the murine antibody recall response to A(H1N1)pdm09 virus.
    Wilson JR; Guo Z; Tzeng WP; Garten RJ; Xiyan X; Blanchard EG; Blanchfield K; Stevens J; Katz JM; York IA
    Virology; 2015 Nov; 485():252-62. PubMed ID: 26318247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique and conserved neutralization epitope in H5N1 influenza viruses identified by an antibody against the A/Goose/Guangdong/1/96 hemagglutinin.
    Zhu X; Guo YH; Jiang T; Wang YD; Chan KH; Li XF; Yu W; McBride R; Paulson JC; Yuen KY; Qin CF; Che XY; Wilson IA
    J Virol; 2013 Dec; 87(23):12619-35. PubMed ID: 24049169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin.
    Doud MB; Lee JM; Bloom JD
    Nat Commun; 2018 Apr; 9(1):1386. PubMed ID: 29643370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.